You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 1, January 13, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (74)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Adverse Effects
 •Alert me on articles by topic

Use of Selective Serotonin Reuptake Inhibitors and Risk of Upper Gastrointestinal Tract Bleeding

A Population-Based Cohort Study

Susanne Oksbjerg Dalton, MD; Christoffer Johansen, MD, PhD; Lene Mellemkjær, MSc, PhD; Henrik Toft Sørensen, MD, PhD; Bente Nørgård, MD; Jørgen H. Olsen, MD, DrSci

Arch Intern Med. 2003;163:59-64.

Background  Selective serotonin reuptake inhibitors (SSRIs) have been suspected of increasing the risk of bleeding. We examined the risk of upper gastrointestinal tract (GI) bleeding with use of antidepressant medication.

Methods  All users of antidepressants in the county of North Jutland, Denmark, from January 1, 1991, to December 31, 1995, were identified in the Pharmaco-Epidemiologic Prescription Database of North Jutland. In the Hospital Discharge Register, hospitalizations for upper GI bleeding were searched among the 26 005 users of antidepressant medications and compared with the number of hospitalizations in the population of North Jutland who did not receive prescriptions for antidepressants.

Results  During periods of SSRI use without use of other drugs associated with upper GI bleeding, we observed 55 upper GI bleeding episodes, which was 3.6 times more than expected (95% confidence interval, 2.7-4.7), corresponding to a rate difference of 3.1 per 1000 treatment years. Combined use of an SSRI and nonsteroidal anti-inflammatory drugs or low-dose aspirin increased the risk to 12.2 (95% confidence interval, 7.1-19.5) and 5.2 (95% confidence interval, 3.2-8.0), respectively. Non-SSRIs increased the risk of upper GI bleeding to 2.3 (95% confidence interval, 1.5-3.4), while antidepressants without action on the serotonin receptor had no significant effect on the risk of upper GI bleeding. The risk with SSRI use returned to unity after termination of SSRI use, while the risks were similarly increased during periods of use and nonuse of non-SSRIs.

Conclusion  Selective serotonin reuptake inhibitors increase the risk of upper GI bleeding, and this effect is potentiated by concurrent use of nonsteroidal anti-inflammatory drugs or low-dose aspirin, whereas an increased risk of upper GI bleeding could not be attributed to other types of antidepressants.


From the Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen (Drs Dalton, Johansen, Mellemkjær, and Olsen); the Department of Medicine M, Aalborg Hospital, and the Department of Clinical Epidemiology, University of Aarhus, Aarhus, Denmark (Drs Nørgård and Sørensen); and the Department of Medicine V, Aarhus University Hospital, Aarhus (Dr Sørensen).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk of Upper Gastrointestinal Tract Bleeding Associated With Selective Serotonin Reuptake Inhibitors and Venlafaxine Therapy: Interaction With Nonsteroidal Anti-inflammatory Drugs and Effect of Acid-Suppressing Agents
de Abajo and Garcia-Rodriguez
Arch Gen Psychiatry 2008;65:795-803.
ABSTRACT | FULL TEXT  

Antidepressant Treatment and Worsening White Matter on Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study
Steffens et al.
Stroke 2008;39:857-862.
ABSTRACT | FULL TEXT  

Increased Bleeding Risk With Concurrent Use of Selective Serotonin Reuptake Inhibitors and Coumarins
Schalekamp et al.
Arch Intern Med 2008;168:180-185.
ABSTRACT | FULL TEXT  

Psychosocial Aspects of Chronic Disease: ESRD as a Paradigmatic Illness
Cukor et al.
J. Am. Soc. Nephrol. 2007;18:3042-3055.
ABSTRACT | FULL TEXT  

Screening, Diagnosis, and Treatment of Depression in Patients with End-Stage Renal Disease
Cohen et al.
CJASN 2007;2:1332-1342.
ABSTRACT | FULL TEXT  

Approach to managing musculoskeletal pain: Acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs?
Hunt et al.
cfp 2007;53:1177-1184.
ABSTRACT | FULL TEXT  

Potential Medical and Surgical Complications of Serotonergic Antidepressant Medications
Looper
Psychosomatics 2007;48:1-9.
ABSTRACT | FULL TEXT  

A Pilot Study of Sertraline for Depression in Age-Related Macular Degeneration
Rovner et al.
AJGP 2006;14:718-719.
FULL TEXT  

SSRIs and gastrointestinal bleeding
Paton and Ferrier
BMJ 2005;331:529-530.
FULL TEXT  

Depression, Alterations in Platelet Function, and Ischemic Heart Disease
Bruce and Musselman
Psychosom. Med. 2005;67:S34-S36.
ABSTRACT | FULL TEXT  

Prospective study of elderly people comparing treatments following first primary care consultation for a symptomatic hip or knee
Linsell et al.
Fam Pract 2005;22:118-125.
ABSTRACT | FULL TEXT  

Nonsteroidal anti-inflammatory analgesics and gastrointestinal protection in palliative care patients
Shah and Thomas
Palliat Med 2004;18:739-740.
 

Association of Risk of Abnormal Bleeding With Degree of Serotonin Reuptake Inhibition by Antidepressants
Meijer et al.
Arch Intern Med 2004;164:2367-2370.
ABSTRACT | FULL TEXT  

Do SSRIs cause gastrointestinal bleeding?
DTB 2004;42:17-18.
ABSTRACT | FULL TEXT  

SSRIs and Upper GI Bleeding: Depressing News?
JWatch Gastroenterology 2003;2003:1-1.
FULL TEXT  

SSRIs and Risk for GI Bleeding
JWatch Psychiatry 2003;2003:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.